TYL:NYSETyler Technologies, Inc. Analysis
Data as of 2026-03-13 - not real-time
$348.22
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Tyler Technologies posted a solid Q4 beat with revenue up year‑over‑year and EPS surpassing estimates, while management outlined an 8.3% revenue growth target for 2026 driven by SaaS adoption and strategic share repurchases. Analyst sentiment has turned more bullish, highlighted by DA Davidson’s upgrade to Buy and a median 27% upside target near $440, reinforcing confidence in the company’s growth trajectory. Fundamentally, the firm delivers healthy margins (gross ~46%, operating ~13%) and generates robust free cash flow, supported by a strong cash position and modest leverage.
However, the stock trades at a forward PE of ~24.5x and a current PE of ~48x, well above the industry average, and the DCF‑derived fair value sits near $221, indicating that the market may be pricing in overly optimistic growth expectations. Technical indicators show a bearish trend with price below the 50‑day and 200‑day moving averages, though the MACD histogram is positive and the signal line turned bullish, suggesting a potential short‑term rebound. High 30‑day volatility (≈69%) and a decreasing volume trend add to the near‑term risk, while the low beta (≈0.64) cushions broader market swings. Investors should weigh the strong earnings momentum and upside from analyst targets against the elevated valuation and volatility when deciding on entry timing.
However, the stock trades at a forward PE of ~24.5x and a current PE of ~48x, well above the industry average, and the DCF‑derived fair value sits near $221, indicating that the market may be pricing in overly optimistic growth expectations. Technical indicators show a bearish trend with price below the 50‑day and 200‑day moving averages, though the MACD histogram is positive and the signal line turned bullish, suggesting a potential short‑term rebound. High 30‑day volatility (≈69%) and a decreasing volume trend add to the near‑term risk, while the low beta (≈0.64) cushions broader market swings. Investors should weigh the strong earnings momentum and upside from analyst targets against the elevated valuation and volatility when deciding on entry timing.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Recent earnings beat but price below key moving averages
- Positive MACD histogram indicating possible short‑term bounce
- Decreasing volume and high short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst upgrades and median price target implying ~27% upside
- Guidance for 8% revenue growth in 2026 with SaaS expansion
- Strong cash flow generation and modest debt levels
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Recurring public‑sector software contracts provide durable revenue base
- Strategic partnership with AWS enhances platform scalability
- Low beta and diversified product suite reduce systemic risk
Key Metrics & Analysis
Financial Health
Revenue Growth6.30%
Profit Margin13.53%
P/E Ratio48.4
ROE8.90%
ROA4.14%
Debt/Equity17.36
P/B Ratio4.1
Op. Cash Flow$653.5M
Free Cash Flow$503.6M
Industry P/E33.8
Technical Analysis
TrendBearish
RSI45.4
Support$291.46
Resistance$377.77
MA 20$342.42
MA 50$380.86
MA 200$491.60
MACDBullish
VolumeDecreasing
Fear & Greed Index72.93
Valuation
Fair Value$220.97
Target Price$443.48
Upside/Downside27.36%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.64
Volatility69.28%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.